Effect of EGFR-TKI retreatment following chemotherapy for advanced non-small cell lung cancer patients who underwent EGFR-TKI

OBJECTIVE: Non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR)-activating mutations have higher response rate and more prolonged survival following treatment with single-agent EGFR tyrosine kinase inhibitor (EGFR-TKI) compared with patients with wild-type EGFR. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Guo-Hao, Zeng, Yun, Fang, Ying, Yu, Shao-Rong, Wang, Li, Shi, Mei-Qi, Sun, Wei-Li, Huang, Xin-En, Chen, Jia, Feng, Ji-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Anti-Cancer Association 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296083/
https://www.ncbi.nlm.nih.gov/pubmed/25610713
http://dx.doi.org/10.7497/j.issn.2095-3941.2014.04.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296083/
https://www.ncbi.nlm.nih.gov/pubmed/25610713
http://dx.doi.org/10.7497/j.issn.2095-3941.2014.04.006

Ejemplares similares